CNS Orphan Diseases

The challenges of drug development in CNS is well known, recent failures of the large phase III trials in Alzheimer's disease illustrates the problem.

8 Apr 2014 at Holiday Inn London - Bloomsbury, London, GB

Pharmaceuticals/Drug Discovery, Medical & Health Care

Submit new post
Thank you for posting.
Share it: